Risk factors for cardiac morbidity and mortality in dialysis patients.
Clinical and echocardiographic manifestations of cardiac disease are frequently present in patients starting end-stage renal disease therapy. Congestive heart failure, ischemic heart disease, systolic dysfunction, concentric left ventricular hypertrophy, and left ventricular dilatation are significant, adverse prognostic indicators, independent of age, diabetes mellitus, and smoking. Risk factors related to the uremic state, which are potentially reversible, include inadequate dialysis, anemia, hypoalbuminemia and hypocalcemia. Hypertension predisposes patients to congestive heart failure, following the development of which hypotension becomes an independent predictor of mortality.
Foley
R N
RN
Division of Nephrology, Memorial University, St. John's Newfoundland, Canada.
Parfrey
P S
PS
D000367:Age Factors; D048909:Diabetes Complications; D006331:Heart Diseases / Q000209:etiology / Q000401:mortality*; D006801:Humans; D006949:Hyperlipidemias / Q000150:complications; D006973:Hypertension / Q000150:complications; D007676:Kidney Failure, Chronic / Q000628:therapy; D009017:Morbidity; D017582:Renal Replacement Therapy; D012307:Risk Factors; D012907:Smoking / Q000009:adverse effects; D014511:Uremia / Q000150:complications